
Telesis Bio Investor Relations Material
Latest events

Q2 2023
Telesis Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Telesis Bio Inc
Access all reports
Telesis Bio Inc. is a synthetic biology company that provides automated solutions for DNA and RNA synthesis. Its core product, the BioXp system, is the world’s first fully automated gene synthesis platform, enabling researchers to rapidly design, build, and clone high-quality synthetic DNA and mRNA. Telesis Bio's technologies are widely used in various applications, including vaccine development, gene and cell therapy, precision medicine, and biologics drug discovery. Telesis Bio is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
DNAY
Country
🇺🇸 United States